Spatiotemporal transcriptomics reveals distinct responses of ALDH1A1-positive and ALDH1A1-negative midbrain dopaminergic neurons to alpha-synuclein overexpression
Carmen-Jeanette Stepek, Eanna B Ryan, Javier Villegas-SalmeróniD, Felicia NewiD, Kalyan Chavda, David Clifford HenshalliD, Donato A. Di MonteiD, Jochen H.M. PrehniD, Ayşe UlusoyiD, Niamh M. C. ConnollyiD
Abstract
Parkinsons disease is characterized by the progressive and preferential degeneration of dopaminergic neurons in the substantia nigra pars compacta, and intraneuronal alpha-synuclein (Syn) accumulation. Dopaminergic neurons (DANs) are anatomically and molecularly heterogeneous, but the impact of Syn pathology on distinct subpopulations is not well defined. One midbrain DAN sub-population expresses Aldehyde Dehydrogenase 1A1 (ALDH1A1), an enzyme that detoxifies aldehyde by-products of dopamine metabolism, and has been associated with differential vulnerability. Here, we applied GeoMx spatial transcriptomics to profile ALDH1A1-positive (ALDH1A1+) and ALDH1A1-negative (ALDH1A1-) DAN subpopulations in the mouse midbrain in situ at 3- and 8-weeks following adeno-associated virus (AAV)-mediated Syn overexpression. Analyzing 10,532 genes, we identified robust transcriptional differences between ALDH1A1+ and ALDH1A1- DANs under control conditions, supporting their characterization as distinct molecular subpopulations. In AAV-Syn-injected mice, we observed increased Snca expression and a reduction in ALDH1A1- DANs in the ipsilateral substantia nigra. Syn overexpression induced subpopulation-specific and time-dependent transcriptional responses, with dysregulation in ALDH1A1- DANs characterized by early down-regulation of pathways related to synaptic function, neurotransmitter handling, and bioenergetics, including glycolysis. In contrast, ALDH1A1+ DANs displayed later up-regulation of genes enriched for Acetyl-CoA and cholesterol metabolism pathways, reflecting subpopulation-specific adaptations to Syn overexpression. Analysis of human single nucleus RNA-sequencing data revealed partial conservation of the metabolic dysregulation signature. Together, our findings show that murine midbrain ALDH1A1+ and ALDH1A1- DANs represent molecularly distinct subpopulations with divergent temporal responses to Syn overexpression, emphasizing the importance of cell-type and disease-stage context in studies of Parkinsons disease mechanisms.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Parkinson's Paradox: Alpha-synuclein's Selective Strike on SNc Dopamine Neurons over VTA
Leah T. Phan, D Miller, … Habibeh Khoshbouei·npj Parkinson s DiseasePeer-reviewed·Jul 11, 2025
- Overexpression of alpha synuclein in Midbrain Dopamine Neurons Reduces Dopamine Release Without Cell Loss and Drives Mild Motor Deficits in Mice
Kelsey Barcomb, Jen-Hsiang T. Hsiao, … Alexandra Nelson·bioRxiv·Mar 17, 2025
- Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegeneration
Sofia Ines Garcia Moreno, Fabian Limani, … Thomas Steinkellner·Experimental NeurologyPeer-reviewed·Sep 15, 2024
- The impact of alpha synuclein overexpression on nigrostriatal transmission
Nikolas Bergum, Andrew G. Yee, … Christopher Ford·bioRxiv·Sep 21, 2026
- A topographical atlas of alpha-Synuclein dosage and cell-type expression in the mouse brain and periphery
Haley M. Geertsma, Zoe A. Fisk, … Maxime W.C. Rousseaux·npj Parkinson s DiseasePeer-reviewed·Mar 19, 2024
- α-Synuclein impairs mitochondrial function and alters cryptochrome regulation in the substantia nigra
Sinéad A. O’Sullivan, Adrian Perdyan, … Donato A. Di Monte·bioRxiv·Aug 21, 2026